Monoamine oxidase inhibitor (MAOI) drugs, like procarbazine, can cause toxic effects in children treated for CNS tumors. This case highlights MAOI risks and potential drug interactions in pediatric oncology.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background: